By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem today said that its Enzo Life Sciences subsidiary has expanded a distribution agreement with Tokyo-based Cosmo Bio.

Cosmo, which has served as a distributor of Enzo Life Sciences products in japan for more than 20 years, will now also promote, sell, and provide high-level technical and customer support for the Enzo Life Sciences products. Enzo also will distribute worldwide Cosmo Bio's catalog of Japanese-manufactured research biotools.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.